eLearning programme to support advanced therapy training in the NHS, UK universities and government bodies

Advanced therapy medicinal products (ATMPs) are medicines for human use, which use genes, tissues or cells to offer ground-breaking new opportunities for the treatment of disease and injury. These therapies are potentially curative and can offer the promise of treating and altering the course of diseases which cannot be addressed adequately by existing pharmaceuticals, offering a lifeline to some patients who may have exhausted all other treatment options.

As part of our ongoing support and delivery of cellular & molecular therapies to NHS patients, we have contributed to a new eLearning programme developed by the Advanced Therapy Treatment Centre (ATTC) network, London Advanced Therapies (LAT) and the Cell and Gene Therapy Catapult (CGTC), in partnership with Health Education England eLearning for healthcare.

The programme is a series of eLearning sessions is designed to provide a core understanding of advanced therapies, how they function in the body, and the steps involved in delivering these medicines. The modules progress from the basics of cell and gene therapy, through to a more in-depth look at products currently being delivered through both commissioned treatments and clinical trials.

Learners will be introduced to the unique challenges of bringing these pioneering advanced therapy treatments to patients, within the usual standard of care, including the often nuanced logistical and handling requirements. 

The sessions, which can be mixed and matched according to the learner’s needs, are: 

• Introduction to advanced therapy medicinal products

• In vivo gene therapies

• Immune effector cell therapy

• Focus on CAR-T cell therapy

• The logistics of ATMPs in hospitals

• Safe use of low temperature transport vessels 

For more information and to access the sessions, visit the programme page 

Ceri Roberts - Scientific Training Manager, Cellular and Molecular Therapies